Fundraising Fox

Vitara

Philadelphia, US · Delaware corporation · 3 known investors

vitara.com ↗

Vitara Biomedical develops medical technology for the care of extremely premature newborns. The company is rooted in neonatology research from Children's Hospital of Philadelphia.

BiotechDeep TechHealthtechMedical Devicesin /vitara-biomedical

Founders & leadership

BL
Bernard LyonsExecutive Officer, Director
AD
Arthur DantchikDirector
JM
James McGloneExecutive Officer, Director
JK
Jeffrey KahnExecutive Officer
NH
Nelson HillDirector
TT
Thomas TodorowDirector
IR
Ian RatcliffeDirector
MK
Manish KothariDirector
DN
Diem NguyenDirector
TF
Ted FjallmanDirector
AF
Alan FlakeinCo-Inventor & Medical Advisor

Investors · 3

First Spark Ventures, LlcMenlo Park
Jazzya InvestmentsAlcobendasvia Martin Varsavsky · inferred
Khosla VenturesMenlo Park · $5K – $50M

Reported raises · per SEC filings

Form D private placements
▶$10MraisedOct 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas TodorowDirector
  • Ian RatcliffeDirector
  • Manish KothariDirector
  • Bernard LyonsExecutive Officer, Director
  • Diem NguyenDirector
  • Ted FjallmanDirector
Offering amount
$50M
Amount sold
$10M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedDec 2023 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Diem NguyenDirector
  • Manish KothariDirector
  • Thomas TodorowDirector
  • Ted FjallmanDirector
  • Rosaleen OskanianExecutive Officer
  • Bernard LyonsDirector
  • James McGloneExecutive Officer, Director
  • John KellyExecutive Officer
  • Ian RatcliffeDirector
Offering amount
$90M
Amount sold
$40M
Minimum investment
$59K
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedMay 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arthur DantchikDirector
  • James McGloneExecutive Officer, Director
  • Jeffrey KahnExecutive Officer
  • Thomas TodorowDirector
  • Diem NguyenDirector
  • Nelson HillDirector
Offering amount
$30M
Amount sold
$20M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news